Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Current development of adeno-associated viral vectors.

Drug news & perspectives - 1 Jun 2005

Romano G

Abstract excerpt

Vectors based on adeno-associated virus (AAV) have recently been used in phase I clinical trials for the treatment of neurological disorders, such as Parkinson's and Canavan's diseases. Indeed, AAV-mediated gene transfer is a promising tool for the delivery of therapeutic gene into the central and peripheral nervous systems. AAV-mediated gene transfer was also applied in phase I and phase II clinical trials for...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenoviridae
Share to Clinical Trials as Topic
Share to Cystic Fibrosis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Dependovirus

Share to Gene Transfer Techniques

Share to Genetic Therapy

Share to Genetic Vectors

Share to Parkinson Disease

Source

Identifiers

PMID: 16193103
DOI: 10.1358/dnp.2005.18.5.917326

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Current development of adeno-associated viral vectors.PMID 16193103Read ↗

Adeno-associated virus therapies: Pioneering solutions for human genetic diseasesSemantic proximity Read ↗

Adeno-Associated Virus Vector for Central Nervous System Gene Therapy.Semantic proximity Read ↗

Adeno-Associated Virus (AAV) as a Vector for Gene TherapySemantic proximity Read ↗

Adeno-associated virus vector-based gene therapies for pediatric diseasesSemantic proximity Read ↗

Towards Clinical Implementation of Adeno-Associated Virus (AAV) Vectors for Cancer Gene Therapy: Current Status and Future PerspectivesSemantic proximity Read ↗

Capsid-Engineering for Central Nervous System-Directed Gene Therapy with Adeno-Associated Virus VectorsSemantic proximity Read ↗

Applications of adeno-associated virus vector-mediated gene delivery for neurodegenerative diseases and psychiatric diseases: Progress, advances, and challengesSemantic proximity Read ↗

Rationale and strategies for the development of safe and effective optimized AAV vectors for human gene therapySemantic proximity Read ↗

Current clinical applications of AAV-mediated gene therapySemantic proximity Read ↗

Biology of adeno-associated viral vectors in the central nervous systemSemantic proximity Read ↗

AAV-Based Gene Therapy: Opportunities, Risks, and Scale-Up StrategiesSemantic proximity Read ↗

Adeno-Associated Virus at 50: A Golden Anniversary of Discovery, Research, and Gene Therapy Success—A Personal PerspectiveSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.